Page last updated: 2024-09-02

2'-5'-oligoadenylate trimer and Kidney Neoplasms

2'-5'-oligoadenylate trimer has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brodsky, I; Carter, WA; Lee, C; Reichenbach, NL; Strayer, DR; Suhadolnik, RJ	1

Trials

1 trial(s) available for 2'-5'-oligoadenylate trimer and Kidney Neoplasms

Article	Year
Ampligen treatment of renal cell carcinoma: changes in 2-5A synthetase, 2-5A oligomer size and natural killer cell activity associated with antitumor response clinically. Progress in clinical and biological research, 1985, Volume: 202 Topics: 2',5'-Oligoadenylate Synthetase; Adenine Nucleotides; Carcinoma, Renal Cell; Clinical Trials as Topic; Humans; Kidney Neoplasms; Killer Cells, Natural; Molecular Weight; Oligoribonucleotides; Poly I-C; Poly U; Polyribonucleotides	1985

Article

Year

Ampligen treatment of renal cell carcinoma: changes in 2-5A synthetase, 2-5A oligomer size and natural killer cell activity associated with antitumor response clinically.

Progress in clinical and biological research, 1985, Volume: 202

Topics: 2',5'-Oligoadenylate Synthetase; Adenine Nucleotides; Carcinoma, Renal Cell; Clinical Trials as Topic; Humans; Kidney Neoplasms; Killer Cells, Natural; Molecular Weight; Oligoribonucleotides; Poly I-C; Poly U; Polyribonucleotides

1985